CN1045955C - 喹啉衍生物及其制法和用途以及含该衍生物的药物组合物 - Google Patents

喹啉衍生物及其制法和用途以及含该衍生物的药物组合物 Download PDF

Info

Publication number
CN1045955C
CN1045955C CN94192410A CN94192410A CN1045955C CN 1045955 C CN1045955 C CN 1045955C CN 94192410 A CN94192410 A CN 94192410A CN 94192410 A CN94192410 A CN 94192410A CN 1045955 C CN1045955 C CN 1045955C
Authority
CN
China
Prior art keywords
ch2ch2ch3
compound
quinoline
mmol
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94192410A
Other languages
English (en)
Chinese (zh)
Other versions
CN1125438A (zh
Inventor
C·I·斯塔克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9302005A external-priority patent/SE9302005D0/xx
Priority claimed from SE9303970A external-priority patent/SE9303970D0/xx
Application filed by Astra AB filed Critical Astra AB
Publication of CN1125438A publication Critical patent/CN1125438A/zh
Application granted granted Critical
Publication of CN1045955C publication Critical patent/CN1045955C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CN94192410A 1993-06-11 1994-06-08 喹啉衍生物及其制法和用途以及含该衍生物的药物组合物 Expired - Fee Related CN1045955C (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
SE93020055 1993-06-11
SE9302005A SE9302005D0 (sv) 1993-06-11 1993-06-11 New active compounds
SE9302005-5 1993-06-11
SE93039709 1993-11-30
SE9303970-9 1993-11-30
SE9303970A SE9303970D0 (sv) 1993-11-30 1993-11-30 New active compounds

Publications (2)

Publication Number Publication Date
CN1125438A CN1125438A (zh) 1996-06-26
CN1045955C true CN1045955C (zh) 1999-10-27

Family

ID=26661770

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94192410A Expired - Fee Related CN1045955C (zh) 1993-06-11 1994-06-08 喹啉衍生物及其制法和用途以及含该衍生物的药物组合物

Country Status (25)

Country Link
US (1) US5889021A (enExample)
EP (1) EP0702672B1 (enExample)
JP (1) JP3623794B2 (enExample)
CN (1) CN1045955C (enExample)
AT (1) ATE196134T1 (enExample)
AU (1) AU680516B2 (enExample)
BR (1) BR9406772A (enExample)
CA (1) CA2164875A1 (enExample)
CZ (1) CZ326095A3 (enExample)
DE (1) DE69425823T2 (enExample)
EE (1) EE03123B1 (enExample)
EG (1) EG20435A (enExample)
ES (1) ES2150494T3 (enExample)
FI (1) FI955896A7 (enExample)
HU (1) HUT75122A (enExample)
IL (1) IL109685A (enExample)
IS (1) IS4164A (enExample)
NO (1) NO305799B1 (enExample)
NZ (1) NZ267740A (enExample)
PL (1) PL177766B1 (enExample)
RU (1) RU2142454C1 (enExample)
SG (1) SG47820A1 (enExample)
SK (1) SK154995A3 (enExample)
TW (1) TW261613B (enExample)
WO (1) WO1994029274A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
AU2002950217A0 (en) 2002-07-16 2002-09-12 Prana Biotechnology Limited 8- Hydroxy Quinoline Derivatives
CN109369656B (zh) * 2015-12-31 2021-05-07 上海医药集团股份有限公司 喹啉类化合物硫酸盐的晶型、制备方法、组合物与应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US509804A (en) * 1893-11-28 Hoof-weight
US4806550A (en) * 1986-09-05 1989-02-21 Smithkline & French Laboratories Limited 4-Amino-3-carbonyl substituted quinolines as inhibitors of gastric acid secretion
US5082848A (en) * 1988-02-25 1992-01-21 Smith Kline & French Laboratories, Ltd. Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibitors
US5082841A (en) * 1989-08-10 1992-01-21 Smithkline Beecham Intercredit B.V. 3-carbonyl-4-amino-8-substituted quinoline compounds useful in inhibiting gastric acid secretions.
WO1992012969A1 (en) * 1991-01-29 1992-08-06 Smithkline Beecham Intercredit B.V. Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
US4042702A (en) * 1973-08-16 1977-08-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogen pyrazole derivatives, a method for producing these halogen pyrazole derivatives, medicaments containing and methods of using them
LU69428A1 (enExample) * 1974-02-20 1975-12-09
US4120966A (en) * 1975-02-03 1978-10-17 Smith Kline & French Laboratories Limited Heterocyclic-methylthioethyl-dithiocarbamates and isothioureas
NO760996L (enExample) * 1975-03-25 1976-09-28 Byk Gulden Lomberg Chem Fab
FR2367750A1 (fr) * 1976-10-14 1978-05-12 Byk Gulden Lomberg Chem Fab Acid
SE448091B (sv) * 1977-12-15 1987-01-19 Roussel Uclaf Nya 2-/(4-kinolinyl)-amino/-5-fluorbensoesyraderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa derivat
LU78804A1 (de) * 1977-12-30 1979-07-20 Byk Gulden Lomberg Chem Fab N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US4243678A (en) * 1977-12-30 1981-01-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylhydrocarbylaminoalkanoic acids, compositions and uses
YU118379A (en) * 1978-05-24 1983-02-28 Byk Gulden Lomberg Chemischefa Process for preparing phenylaminothiophene acetic acid
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
FI68835C (fi) * 1979-08-03 1985-11-11 Byk Gulden Lomberg Chem Fab Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-minoacyl-1,4,9,10-tetrahydropyrazolo(4,3-b)(1,5)bensodiaz epn-10-oner
EP0024638A1 (en) * 1979-08-30 1981-03-11 Byk Gulden Lomberg Chemische Fabrik GmbH Substituted quinolinone-alkanecarboxylic acids, their preparation, and medicaments containing them
EP0025192B1 (de) * 1979-09-07 1983-05-11 Byk Gulden Lomberg Chemische Fabrik GmbH Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
ES8202780A1 (es) * 1979-10-31 1982-03-01 Byk Gulden Lomberg Chem Fab Procedimiento para la preparacion de acidos oxocarboxilicos sustituidos
US4381301A (en) * 1980-05-07 1983-04-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted tricyclic thieno compounds, their synthesis, their use, their compositions and their medicaments
US4337267A (en) * 1980-08-25 1982-06-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenalkoxyalkyl- and phenoxyalkyl-substituted oxiranecarboxylic acids, their use and medicaments containing them
US4430339A (en) * 1980-08-29 1984-02-07 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung Substituted oxiranecarboxylic acids, their preparation and their use as medicaments
EP0057428B1 (de) * 1981-02-02 1985-04-10 Byk Gulden Lomberg Chemische Fabrik GmbH Tricyclische Pyrrole, Verfahren zu ihrer Herstellung, ihre Anwendung sowie sie enthaltende Arzneimittel
FI80022C (fi) * 1982-07-05 1990-04-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart karbostyrilderivat.
DK585485A (da) * 1984-12-18 1986-08-08 Utsuka Pharm Co Ltd Tetrahydroquinolinderivat, imidazopyridinderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat med mindst en saadan forbindelse
US5250527A (en) * 1985-10-24 1993-10-05 Smithkline & French Laboratories Limited Pyridyl containing benzimidazoles, compositions and use
GB8717644D0 (en) * 1987-07-24 1987-09-03 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5049567A (en) * 1988-02-25 1991-09-17 Smithkline Beckman Intercredit B.V. Substituted 4-aminoquinazoline derivatives and method of use
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
GB8908229D0 (en) * 1989-04-12 1989-05-24 Smithkline Beckman Intercredit Compounds
GB8910722D0 (en) * 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
JPH04211661A (ja) * 1990-03-28 1992-08-03 Otsuka Pharmaceut Co Ltd キノリン誘導体及び該誘導体を含有する抗潰瘍剤
GB9126438D0 (en) * 1991-12-12 1992-02-12 Smithkline Beecham Intercredit New quinoline derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US509804A (en) * 1893-11-28 Hoof-weight
US4806550A (en) * 1986-09-05 1989-02-21 Smithkline & French Laboratories Limited 4-Amino-3-carbonyl substituted quinolines as inhibitors of gastric acid secretion
US5082848A (en) * 1988-02-25 1992-01-21 Smith Kline & French Laboratories, Ltd. Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibitors
US5082841A (en) * 1989-08-10 1992-01-21 Smithkline Beecham Intercredit B.V. 3-carbonyl-4-amino-8-substituted quinoline compounds useful in inhibiting gastric acid secretions.
WO1992012969A1 (en) * 1991-01-29 1992-08-06 Smithkline Beecham Intercredit B.V. Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion

Also Published As

Publication number Publication date
FI955896A0 (fi) 1995-12-08
EP0702672A1 (en) 1996-03-27
EE03123B1 (et) 1998-10-15
NO305799B1 (no) 1999-07-26
DE69425823D1 (de) 2000-10-12
ES2150494T3 (es) 2000-12-01
PL311957A1 (en) 1996-03-18
AU7012194A (en) 1995-01-03
JPH09510951A (ja) 1997-11-04
DE69425823T2 (de) 2001-01-18
IS4164A (is) 1994-12-12
RU2142454C1 (ru) 1999-12-10
SG47820A1 (en) 1998-04-17
NO954928D0 (no) 1995-12-05
US5889021A (en) 1999-03-30
SK154995A3 (en) 1996-09-04
CN1125438A (zh) 1996-06-26
CZ326095A3 (en) 1996-05-15
IL109685A0 (en) 1994-11-28
NZ267740A (en) 1997-05-26
EG20435A (en) 1999-04-29
FI955896L (fi) 1995-12-08
HUT75122A (en) 1997-04-28
AU680516B2 (en) 1997-07-31
ATE196134T1 (de) 2000-09-15
CA2164875A1 (en) 1994-12-22
BR9406772A (pt) 1996-02-21
TW261613B (enExample) 1995-11-01
PL177766B1 (pl) 2000-01-31
WO1994029274A1 (en) 1994-12-22
IL109685A (en) 1999-03-12
HU9503529D0 (en) 1996-02-28
JP3623794B2 (ja) 2005-02-23
FI955896A7 (fi) 1995-12-08
NO954928L (no) 1995-12-05
EP0702672B1 (en) 2000-09-06

Similar Documents

Publication Publication Date Title
CN1174980C (zh) 抑制胃酸分泌的咪唑并吡啶衍生物
CN1022487C (zh) 制备新的药物化合物
CN1059673C (zh) 降血脂1,4－苯并氮杂䓬－1,1－二氧化物
CN100335054C (zh) 喹诺酮羧酸和萘啶酮羧酸衍生物在治疗幽门螺杆菌感染和其相关的胃十二指肠疾病中的应用
CN87106163A (zh) 新颖的取代喹啉衍生物及其制备方法
CN86107491A (zh) 新的喹啉衍生物及其制备方法
CN1032361C (zh) 咪唑并哒嗪化合物的制备方法
CN1048242C (zh) 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物
CN1037441C (zh) 二环胺衍生物及含有该衍生物的抗菌剂
CN1100414A (zh) 含有新型喹啉衍生物的药用复合物的制备方法
CN1508136A (zh) 四氢吡啶并化合物
CN86100126A (zh) 6，7-双取代-1-环丙基-1，4二氢-4-氧代-1，8-萘啶-3-羧酸的制备方法及其应用
CN1221419A (zh) 酰胺衍生物
CN1038642A (zh) 稠合吡唑3-氧代-丙腈衍生物的制备方法
CN1045955C (zh) 喹啉衍生物及其制法和用途以及含该衍生物的药物组合物
CN1021967C (zh) 新的喹啉衍生物的制备方法
CN1311785A (zh) 作为甘氨酸拮抗剂的四氢喹啉衍生物
CN1245400C (zh) N－取代苯并噻唑磺胺衍生物
CN1749256A (zh) 一类新的噁唑烷酮衍生物、其制备方法和用途
CN86102350A (zh) 新型化合物的制备方法
CN1063747C (zh) 喹诺酮－及二氮杂萘酮羧酸衍生物
CN1172478A (zh) 喹诺酮衍生物抗血栓形成药
CN88101987A (zh) 喹啉羧酸衍生物和含有它们的抗菌剂
CN1856491A (zh) 作为可诱导的no合成酶抑制剂的咪唑并吡啶衍生物
CN1173177A (zh) 6－甲氧基－1h－苯并三唑－5－甲酰胺衍生物、其制造方法及含有该衍生物的医药组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee